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Background
Cushing’s disease (CD) has demonstrated subclinical
myocardial involvement such as left ventricular (LV)
hypertrophy and both diastolic and systolic impairment.
Although myocardial fibrosis may play an important
role in such myocardial alterations, the new T1 mapping
techniques have not yet been used in CD to characterize
the myocardium at baseline and to evaluate the effect of
treatment on myocardial T1 values.
Methods
This is a longitudinal pilot study performed in an aca-
demic center from Sept 2009 to Jan 2013. Ten consecu-
tive patients (36±15 years, 9 women) with active CD
were included and matched with ten healthy volunteers
(36±9 years, 9 women) on age, sex and heart rate. Inclu-
sion criteria were: age between 15 and 60 years and
newly diagnosed and untreated CD. Subjects had a car-
diac MRI exam shortly after diagnosis and a follow-up
exam on average 6 month after cortisol normalization.
Imaging protocol included MOLLI T1 mapping
sequences before and after contrast injection and late
gadolinium enhancement (LGE) 10 minutes after contrast
injection. Average T1 values from an entire mid-ventricu-
lar slice were recorded for each patient before and after
treatment and presence of LGE was visually noted.
Results
While no significant differences were noted between
patients and controls in terms of BMI (p=0.08), signifi-
cantly higher systolic and diastolic pressures were
observed in CD (120±14 vs. 100±13, p=0.002 and 75±10
vs. 73±34 mmHg, p=0.023 respectively). No patient had
LGE.
Before cortisol normalization, native myocardial T1
was increased in CD patients, as compared to controls
(1031±106 ms, 959±45 ms, p=0.049). T1 values 15 min-
utes after enhancement were not significantly increased.
After treatment, native T1 decreased markedly (830±78
ms vs. 1031±106, p=0.004) becoming even lower than
controls (p=0.009). T1 value after injection decreased
significantly (respectively (p=0.039) in CD patients,
reaching values significantly lower than those of controls
(p=0.005). These findings favor the hypothesis of differ-
ential resolution of edema, interstitial fibrosis induced
by CD and steatosis caused by metabolic syndrome
which seems to persist.
Before treatment, left ventricular ejection fraction was
decreased in patients (p<0.028) and left ventricular mass
was increased (p=0.076). After treatment, both para-
meters tended to normalize without reaching statistical
significance.
Conclusions
The drastic reduction in T1 values after treatment high-
light the complexity of myocardial changes and the
potential role of other confounders affecting T1 such as
water and fat content. T1 after injection need further
investigation. Native myocardial T1 is a potential tool to
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Figure 1 Myocardial segmentation for native T1 maps, corresponding images. a) Cine SSFP b) Late gadolinium enhancement c) Epicardial
and endocardial borders drawn manually on an original grayscale MOLLI image d) Superimposition T1 map and corrected borders to exclude
left ventricular cavity and epicardial fat.
Figure 2 Comparison of left ventricular myocardial mass (a), mass/end-diastolic volume (b), left ventricular ejection fraction (c) stroke
volume (d), myocardial native T1 value (e) myocardial T1 value 15mn after injection in controls and patients before and after treatment.
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